Literature DB >> 33342587

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Catherine M Otto, Rick A Nishimura, Robert O Bonow, Blase A Carabello, John P Erwin, Federico Gentile, Hani Jneid, Eric V Krieger, Michael Mack, Christopher McLeod, Patrick T O'Gara, Vera H Rigolin, Thoralf M Sundt, Annemarie Thompson, Christopher Toly.   

Abstract

AIM: This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use.
METHODS: A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, Cochrane, Agency for Healthcare Research and Quality Reports, and other selected database relevant to this guideline. STRUCTURE: Many recommendations from the earlier valvular heart disease guidelines have been updated with new evidence and provides newer options for diagnosis and treatment of valvular heart disease. This summary includes only the recommendations from the full guideline which focus on diagnostic work-up, the timing and choice of surgical and catheter interventions, and recommendations for medical therapy. The reader is referred to the full guideline for graphical flow charts, text, and tables with additional details about the rationale for and implementation of each recommendation, and the evidence tables detailing the data considered in developing these guidelines.
Copyright © 2021 American College of Cardiology Foundation and the American Heart Association, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AHA Scientific Statements; anticoagulation therapy; aortic regurgitation; aortic stenosis; bicuspid aortic valve; cardiac surgery; infective endocarditis; mitral regurgitation; mitral stenosis; mitral transcatheter edge-to-edge repair; prosthetic valve; pulmonic regurgitation; pulmonic stenosis; transcatheter aortic valve replacement or implantation; tricuspid regurgitation; tricuspid stenosis; valvular heart disease

Year:  2020        PMID: 33342587     DOI: 10.1016/j.jacc.2020.11.035

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  64 in total

1.  2020 update of the Austrian Society of Cardiology (ÖKG) and the Austrian Society of Cardiac Surgery (ÖGHTG) on the position statement of the ÖKG and ÖGHTG for transcatheter aortic valve implantation 2011.

Authors:  Gudrun Lamm; Matthias Hammerer; Uta C Hoppe; Martin Andreas; Rudolf Berger; Ronald K Binder; Nikolaos Bonaros; Georg Delle-Karth; Matthias Frick; Michael Grund; Bernhard Metzler; Thomas Neunteufl; Philipp Pichler; Albrecht Schmidt; Wilfried Wisser; Andreas Zierer; Rainald Seitelberger; Michael Grimm; Alexander Geppert
Journal:  Wien Klin Wochenschr       Date:  2021-03-23       Impact factor: 1.704

Review 2.  New strategies in the management of valvular heart disease : A critical appraisal on the top 10 messages of the 2020 ACC/AHA guidelines for the management of patients with valvular heart disease.

Authors:  Gudrun Lamm
Journal:  Wien Klin Wochenschr       Date:  2021-05-31       Impact factor: 1.704

Review 3.  Staphylococcus Aureus Infective Endocarditis: JACC Patient Pathways.

Authors:  Julia Grapsa; Christopher Blauth; Y S Chandrashekhar; Bernard Prendergast; Blair Erb; Michael Mack; Valentin Fuster
Journal:  JACC Case Rep       Date:  2021-11-15

Review 4.  Sex Differences and Similarities in Valvular Heart Disease.

Authors:  Jacqueline T DesJardin; Joanna Chikwe; Rebecca T Hahn; Judy W Hung; Francesca N Delling
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

5.  Cardiovascular Outcomes in Aortopathy: GenTAC Registry of Genetically Triggered Aortic Aneurysms and Related Conditions.

Authors:  Kathryn W Holmes; Sheila Markwardt; Kim A Eagle; Richard B Devereux; Jonathan W Weinsaft; Federico M Asch; Scott A LeMaire; Cheryl L Maslen; Howard K Song; Dianna M Milewicz; Siddharth K Prakash; Dongchuan Guo; Shaine A Morris; Reed E Pyeritz; Rita C Milewski; William J Ravekes; H C Dietz; Ralph V Shohet; Michael Silberbach; Mary J Roman
Journal:  J Am Coll Cardiol       Date:  2022-05-31       Impact factor: 27.203

6.  Recent Evidence and Initial Experiences of Transcatheter Edge-to-Edge Repair of the Mitral Valve in South Korea.

Authors:  Sung-Jin Hong; Jung-Sun Kim; Geu-Ru Hong
Journal:  J Chest Surg       Date:  2021-06-05

Review 7.  Coronary Assessment and Revascularization Before Transcutaneous Aortic Valve Implantation: An Update on Current Knowledge.

Authors:  Muhammad Sabbah; Thomas Engstrøm; Ole De Backer; Lars Søndergaard; Jacob Lønborg
Journal:  Front Cardiovasc Med       Date:  2021-05-21

8.  Long-Term Results (up to 20 Years) of 19 mm or Smaller Prostheses in the Aortic Position. Does Size Matter? A Propensity-Matched Survival Analysis.

Authors:  Horea Feier; Andrei Grigorescu; Lucian Falnita; Oana Rachita; Marian Gaspar; Constantin T Luca
Journal:  J Clin Med       Date:  2021-05-11       Impact factor: 4.241

Review 9.  The New Challenge for Heart Endocarditis: From Conventional Prosthesis to New Devices and Platforms for the Treatment of Structural Heart Disease.

Authors:  Francesco Nappi; Adelaide Iervolino; Sanjeet Singh Avtaar Singh
Journal:  Biomed Res Int       Date:  2021-06-14       Impact factor: 3.411

Review 10.  Transcatheter Repair and Replacement Technologies for Mitral Regurgitation: a European Perspective.

Authors:  Joris F Ooms; Nicolas M Van Mieghem
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.